Cargando…
Host – virus – drug interactions as determinants of COVID-19’s phenotypes: A data-driven hypothesis
There is a growing body of evidence on the significance of interactions between comorbidities, their treatments and COVID-19 clinical phenotypes. The hypothesis explored herein is that pharmaceutical compounds currently in use are affecting COVID-19 susceptibility and phenotypes by overlapping trans...
Autor principal: | Vavougios, George D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494558/ https://www.ncbi.nlm.nih.gov/pubmed/33254579 http://dx.doi.org/10.1016/j.mehy.2020.110275 |
Ejemplares similares
-
A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: Potential implications for the SARS-CoV-2 modus operandi
por: Vavougios, George D.
Publicado: (2020) -
Host proteases as determinants of coronaviral neurotropism and virulence
por: Vavougios, George D.
Publicado: (2020) -
COVID-19 Phenotypes and Comorbidity: A Data-Driven, Pattern Recognition Approach Using National Representative Data from the United States
por: Vavougios, George D., et al.
Publicado: (2022) -
WITHDRAWN: Selenium – associated gene signatures within
the SARS-CoV-2 – host genomic interaction interface
por: Vavougios, George D.
Publicado: (2020) -
Letter to the editor: The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in developing a COVID-19 comorbidity-based host risk score
por: Vavougios, George D.
Publicado: (2020)